Our findings suggest that suppression of B7-H4 and recruitment and accumulation of activated cytotoxic CD8 T cells in the tumor microenvironment might lead to enhanced cytotoxic T-lymphocyte-mediated killing of infected cells. The gene discussed is VTCN1; the disease is neoplasm.